RMC-6236 + gemcitabine and nab-paclitaxel for pancreatic cancer (RMC-GI-102_C)

Study Details

Full Title

[RMC-GI-102 C&F] A Platform Study of RAS(ON) Inhibitors in Patients with Gastrointestinal Solid Tumors

Principal Investigator

John
Strickler

Protocol Number

PRO00115670

NCT ID

NCT06445062

Phase

I/II

Enrollment Status

Open to Enrollment